SCHEMBL574056

SCHEMBL574056

CN(C)c1cc(C(=O)O)cc(S(N)(=O)=O)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.45
CA2 P00918 13/20 0.42
CA1 P00915 12/20 0.42
CA4 P22748 4/20 0.42
CA12 O43570 4/20 0.42
CA6 P23280 4/20 0.42
CA5A P35218 4/20 0.42
CA7 P43166 4/20 0.42
CA9 Q16790 4/20 0.42
CA14 Q9ULX7 4/20 0.42
CA5B Q9Y2D0 4/20 0.42
CA13 Q8N1Q1 3/20 0.42
CA3 P07451 3/20 0.42
CISD1 Q9NZ45 1/20 0.42
CYP2C19 P33261 3/20 0.42
CYP2D6 P10635 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574542 0.83 KMT2A (0.46) PKMCA2CA1CA4CA12
SCHEMBL9042101 0.80 CA1 (0.56) PKMCA2CA1CA4CA12
SCHEMBL574554 0.79 CISD1 (0.43) PKMCA2CA1CA4CA12
SCHEMBL11756625 0.78 CA1 (0.47) PKMCA2CA1CA4CA12
SCHEMBL2880823 0.78 CDC25B (0.47) PKMCA2CA1CA4CA12
SCHEMBL574256 0.76 PKM (0.44) PKMCA2CA1CA4CA12
SCHEMBL573694 0.76 PKM (0.44) PKMCA2CA1CA4CA12
SCHEMBL572711 0.75 LMNA (0.62) PKMCA2CA1CA12CA7
SCHEMBL12831123 0.74 NEU3 (0.48) PKMCA2CA1CA4CA12
SCHEMBL9737103 0.74 CA2 (0.39) PKMCA2CA1CA4CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed